Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease
Author(s) -
Patrick W. Serruys,
MarieClaude Morice,
A. Pieter Kappetein,
Antonio Colombo,
David R. Holmes,
Michael J. Mack,
Elisabeth Ståhle,
Ted Feldman,
Marcel van den Brand,
Eric J. Bass,
Nic Van Dyck,
Katrin Leadley,
Keith D. Dawkins,
Friedrich W. Mohr
Publication year - 2009
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa0804626
Subject(s) - medicine , conventional pci , percutaneous coronary intervention , cardiology , myocardial infarction , revascularization , coronary artery disease , stroke (engine) , artery , mechanical engineering , engineering
Percutaneous coronary intervention (PCI) involving drug-eluting stents is increasingly used to treat complex coronary artery disease, although coronary-artery bypass grafting (CABG) has been the treatment of choice historically. Our trial compared PCI and CABG for treating patients with previously untreated three-vessel or left main coronary artery disease (or both).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom